Type III Arch Configuration as a Risk Factor for Carotid Artery Stenting: A Systematic Review of Contemporary Guidelines on Management of Carotid Artery Stenosis.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 15 03 2020
revised: 14 04 2020
accepted: 15 04 2020
pubmed: 28 4 2020
medline: 24 11 2020
entrez: 28 4 2020
Statut: ppublish

Résumé

Type III arch configuration is frequently reported as a stroke risk factor for carotid angioplasty and stenting (CAS). We reviewed contemporary guidelines on management of carotid artery stenosis to assess the clinical relevance attributed to this anatomic feature in current clinical practice. The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The PubMed, EMBASE, and Web of Science databases were searched to identify all guidelines on extracranial carotid disease published between January 2008 and March 2020. A total of 435 articles were screened. For multiple guidelines from the same writing group, only the most recent updated version was considered. Eighteen documents were identified for qualitative analysis. Four guidelines specifically reported type III arch as a predictive factor of periprocedural complications after CAS. Two of them also provided a low level of evidence of their recommendation. None of the documents indicated the exact criteria for aortic arch classification. Three different methods to describe type III arch configuration were identified. Type III arch configuration is inconsistently included among stroke risk factors for CAS in contemporary guidelines, and variably defined. Further studies on the level of concordance between the 3 existing definition criteria are warranted.

Sections du résumé

BACKGROUND BACKGROUND
Type III arch configuration is frequently reported as a stroke risk factor for carotid angioplasty and stenting (CAS). We reviewed contemporary guidelines on management of carotid artery stenosis to assess the clinical relevance attributed to this anatomic feature in current clinical practice.
METHODS METHODS
The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The PubMed, EMBASE, and Web of Science databases were searched to identify all guidelines on extracranial carotid disease published between January 2008 and March 2020. A total of 435 articles were screened. For multiple guidelines from the same writing group, only the most recent updated version was considered. Eighteen documents were identified for qualitative analysis.
RESULTS RESULTS
Four guidelines specifically reported type III arch as a predictive factor of periprocedural complications after CAS. Two of them also provided a low level of evidence of their recommendation. None of the documents indicated the exact criteria for aortic arch classification. Three different methods to describe type III arch configuration were identified.
CONCLUSIONS CONCLUSIONS
Type III arch configuration is inconsistently included among stroke risk factors for CAS in contemporary guidelines, and variably defined. Further studies on the level of concordance between the 3 existing definition criteria are warranted.

Identifiants

pubmed: 32339684
pii: S0890-5096(20)30338-1
doi: 10.1016/j.avsg.2020.04.019
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-509

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Massimiliano M Marrocco-Trischitta (MM)

Clinical Research Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy; Vascular Surgery Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy. Electronic address: massimiliano.marroccotrischitta@grupposandonato.it.

Irene Baroni (I)

Clinical Research Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy.

Renato Vitale (R)

Clinical Research Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy.

Giovanni Nava (G)

Vascular Surgery Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy.

Giovanni Nano (G)

Vascular Surgery Unit, Cardiovascular Department, IRCCS Policlinico San Donato, Milan, Italy; Department of "Scienze Biomediche per la Salute", University of Milan, Milan, Italy.

Francesco Secchi (F)

Department of "Scienze Biomediche per la Salute", University of Milan, Milan, Italy; Division of Radiology, IRCCS Policlinico San Donato, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH